Quick Answer
Burning Rock Biotech Ltd reported Stockholders Equity of $79.57 million for fiscal year 2024.
Burning Rock Biotech Ltd Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | $79.57M | -89.6% |
| 2023 | $768.41M | -33.7% |
| 2022 | $1.16B | -37.2% |
| 2021 | $1.85B | -23.8% |
| 2020 | $2.42B | +371.6% |
| 2019 | -$891.49M | -47.7% |
| 2018 | -$603.46M | -62.2% |
| 2017 | -$372.16M | — |
- Burning Rock Biotech Ltd showed a decrease of -89.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2017–2024 period, Burning Rock Biotech Ltd’s stockholders equity has grown by 121.4% (from -$372.16 million to $79.57 million).
- The most recent figure is from Burning Rock Biotech Ltd’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: